Company InformationBoard of Directors

Mitsuo Sawai joined Sawai Pharmaceutical in January 1989 after having worked for Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.) for approximately seven years. In Sawai Pharmaceutical, he has served in various capacities such as Director, Deputy Vice President of Sales Division, and General Manager of Sales Planning Department; Senior Managing Director and Vice President of Sales Division; and President and Representative Director. Since June 2020, he has been serving as the Chairman and Representative Director. He assumed the role of chairman of Sawai Group Holdings on April 1, 2021.

Kenzo Sawai joined Sawai Pharmaceutical in April 2001 after having worked for Sumitomo Pharmaceuticals Co., Ltd., which is currently Sumitomo Dainippon Pharma Co., Ltd. for approximately six years. In Sawai Pharmaceutical, he has served in various capacities such as Director and Vice President of Corporate Strategy Department; Senior Executive Officer and Deputy Vice President of Sales Division; Senior Managing Executive Officer and Supervisor of Sales Division; and Supervisor of Research & Development Division. He has also served as the Chairman of the Board of Upsher-Smith Laboratories. Since June 2020, he has been serving as the President and Representative Director. He became the deputy chairman of Sawai Group Holdings on April 1, 2021.

Kazuhiko Sueyoshi joined Sawai Pharmaceutical in April 2012 after having worked for The Sumitomo Bank, Limited, which is currently Sumitomo Mitsui Banking Corporation, for more than 30 years. In Sawai Pharmaceutical, he has served in various capacities such as General Manager of Controller Department, Executive Officer and Deputy Vice President of Corporate Administration Division. At affiliates of Sawai Pharmaceutical, he had also served as the Executive Administration of Upsher-Smith Laboratories. Since June 2018, he had served as the Director, Senior Executive Officer and Vice President of Corporate Administration Division of Sawai Pharmaceutical as well as a Director of Medisa Shinyaku Inc. and a Director of Kaken Shoyaku Co., Ltd., both of which are affiliates of Sawai Pharmaceutical. He was appointed president of Sawai Group Holdings on April 1, 2021.

Toru Terashima joined Sawai Pharmaceutical in January 2016 after having worked for Sumitomo Chemical Company, Limited, and Sumitomo Pharmaceuticals Co., Ltd., which is currently Sumitomo Dainippon Pharma Co., Ltd., for more than 30 years. In Sawai Pharmaceutical, he has served in various capacities such as Corporate Officer and Executive Officer. Since June 2019, he has been serving as the Director, Senior Executive Officer and Vice President of Reliability Assurance Division. He became Board member of Sawai Group Holdings on April 1, 2021.

Masatoshi Ohara is an attorney admitted to practice law both in Japan, specifically as an attorney admitted as a member of the Osaka Bar Association, and the state of New York. In April 1979, he joined Kikkawa Sogo Law Offices, which is currently Kikkawa Law Offices, where he made partner in January 1988. He was appointed as a member of the Board of Directors of the Kinki Federation of Bar Associations. He was also appointed as the President of the Osaka Bar Association and the Vice President of the Japan Federation of Bar Associations. Since June 2019, he has served as an external director of Sawai Pharmaceutical. Outside Sawai Pharmaceutical, he concurrently serves as an outside director of Teijin Frontier Co., Ltd. He retired from the position of the external director of Sawai Pharmaceutical and was appointed to the external director of Sawai Group Holdings on April 1, 2021.

Nawomi Todo obtained a medical license in June 1984 and served as a staff doctor at Osaka University Hospital, Osaka Police Hospital (Association of Osaka Police Foundation), and Nissay Hospital, which is currently Nippon Life Hospital. Since January 2002, she has served as a staff doctor at Osaka-tetsusho Health Insurance Society. She also obtained a Certified Occupational Physician Qualification from the Japan Medical Association in January 2007. Since 2015, she has served as an external director of Sawai Pharmaceutical. She retired from the position of the external director of Sawai Pharmaceutical and was appointed to the external director of Sawai Group Holdings on April 1, 2021.

Joined the Company; General Manager, Controller Department of the Company

General Manager, General Affairs Department of the Company

Standing Audit & Supervisory Board Member of the Company

Audit & Supervisory Board Member of Sawai Group Holdings and Sawai Pharmaceutical

Registered as an attorney, joined Kogoshi Takizawa Law Office (currently, Kobe-Kaito Law Office)

Partner of Kobe-Kaito Law Office (incumbent)

Audit & Supervisory Board Member of Sawai Pharmaceutical

President, Hyogo-ken Bar Association

External Audit & Supervisory Board Member of Sawai Group Holdings

Enterprise Examination Department, Osaka Regional Taxation Bureau

District Director, Higashi Yodogawa Tax Office

District Director, Himeji Tax Office

Established a certified tax accountant office, and assumed the position of president (incumbent)

Audit & Supervisory Board Member of Sawai Pharmaceutical

External auditor of MIWA CORPORATION (incumbent)

External Audit & Supervisory Board Member of Sawai Group Holdings